Markets & Investing
Hong Kong is the most attractive investment destination worldwide: BMI Research
Hong Kong is the most attractive investment destination worldwide: BMI Research
Thanks to highly developed logistics network.
Asia Pacific H1 equity offerings increase 26.5% from same period in 2014
India banks saw most common equity offerings.
Prime street shop values dipped 2.5% in 2Q15
It's been bitten by the volatility bug.
Asia Pacific's HNWIs jumped by 8.5% to 4.69m
Their wealth rocketed to a whopping US$15.8tr.
HSBC's Hong Kong PMI falls to 48.6 in April
The private sector contracted much faster.
Hang Seng to divest up to 4.99% of Industrial Bank stake
It'll be HK$22.08 per share.
Stock Connect impact on Hong Kong's Grade-A office market 'colossal'
It helps China connect with the globe, too.
Here are attention-grabbing moves from companies boosting returns
Considering a slow-growth environment.
Hong Kong equity funds record US$24m in inflows in mid-April
There were flows despite foreign fund absence.
Here's how investors can predict the next big correction in Hang Seng Index
It's been everybody's concern now.
Hang Seng Index finally breaks out, advances on 2007's record high
Bubble warnings have emerged.
Almost 4 in 10 Hong Kong adults invested in the stock market
Stock investors hold $200,000 in stockholdings.
Asian central bankers expect US to raise rates soon
Are the banks prepared for the impact?
Asian exports, investments, retail sales remain sluggish amidst oil price drop
Should Asian economies be bothered as early as now?
60% of Asia-Pacific companies bullish over increase in strategic sales
Companies will be more involved in divestments.
Wharf Holdings net profit drops 32% y/y to HK$8.2b
What's the main source of disappointment?
Hong Kong and Singapore investors most confident to invest among Asian peers
But overall intention to invest has moderated.
Commentary
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation